First Manic Attack During COVID-19 Treatment: A Case Report
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
On March 11, 2020, the World Health Organization declared that the infection of novel coronavirus identified in Wuhan, China, is a pandemic. Various studies have shown that SARS-CoV-2 infection can trigger psychiatric effects such as anxiety, depression, and bipolar disorder. Here, we reported a case with no significant psychiatric history who experienced first-episode mania during the COVID-19 treatment. On the third day of hospitalization, the patient’s mood was elevated, she thought she can treat other patients with her special power, she was talkative and irritable. Olanzapine 20 mg was started and the patient’s score on the Young Mania Rating Scale decreased on the 17th day. Psychiatric outcomes associated with covid 19 are just emerging and it seems likely to be a potential engagement for psychiatric professionals in the future. More studies are required in terms of the treatment, course, and follow-up of psychiatric sequelae in these patients.
Abstract
On March 11, 2020, the World Health Organization declared that the infection of novel coronavirus identified in Wuhan, China, is a pandemic. Various studies have shown that SARS-CoV-2 infection can trigger psychiatric effects such as anxiety, depression, and bipolar disorder. Here, we reported a case with no significant psychiatric history who experienced first-episode mania during the COVID-19 treatment. On the third day of hospitalization, the patient’s mood was elevated, she thought she can treat other patients with her special power, she was talkative and irritable. Olanzapine 20 mg was started and the patient’s score on the Young Mania Rating Scale decreased on the 17th day. Psychiatric outcomes associated with covid 19 are just emerging and it seems likely to be a potential engagement for psychiatric professionals in the future. More studies are required in terms of the treatment, course, and follow-up of psychiatric sequelae in these patients.
참고문헌 (20)
- "Rolling updates on coronavirus disease (COVID-19)"[URL]
- Montalvan V, "Neurological manifestations of COVID-19 and other coronavirus infections : a systematic review", Clin Neurol Neurosurg, 194, pp.105921~ (2020)
- "Coronavirus disease (COVID-19) situation dashboard. ArcGIS. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE)", Johns Hopkins University, ~ (2020)
- Rogers JP, "Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections : a systematic review and meta-analysis with comparison to the COVID-19pandemic", Lancet Psychiatry, 7, pp.611~627 (2020)
- Ather Muneer, "Staging Models in Bipolar Disorder: A Systematic Review of the Literature", Clinical Psychopharmacology and Neuroscience, 14(2), pp.117~130 (2016), 대한정신약물학회
- Sorcha Bolton, "Bipolar disorder: Trimodal age‐at‐onset distribution", Bipolar Disorders, 23(4), pp.341~356 (2021), Wiley[DOI]
- Walls AC, "Structure, function, and antigenicity of the SARS-CoV-2spike glycoprotein", Cell, 181, pp.281~292 (2020)
- Baig AM, "Evidence of the COVID-19 virus targeting the CNS : tissue distribution, host-virus interaction, and proposed neurotropic mechanisms", ACS Chem Neurosci, 11, pp.995~998 (2020)
- Rosenblat JD, "Bipolar disorder and inflammation", Psychiatr Clin North Am, 39, pp.125~137 (2016)
- O’Brien SM, "Cytokine profiles in bipolar affective disorder : focus on acutely ill patients", J Affect Disord, 90, pp.263~267 (2006)
- Brietzke E, "Towards a multifactorial approach for prediction of bipolar disorder in at risk populations", J Affect Disord, 140, pp.82~91 (2012)
- Himmerich H, "Cytokine research in depression : principles, challenges, and open questions", Front Psychiatry, 10, pp.30~ (2019)
- Han H, "Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors", Emerg Microbes Infect, 9, pp.1123~1130 (2020)
- Chen G, "Clinical and immunological features of severe and moderate coronavirus disease 2019", J Clin Invest, 130, pp.2620~2629 (2020)
- Eduardo H. L. Umeoka, "The Role of Stress in Bipolar Disorder", Bipolar Disorder: From Neuroscience to Treatment, pp.21~39 (2020), Springer International Publishing[DOI]
- Aldinger F, "Environmental factors, life events, and trauma in the course of bipolar disorder", Psychiatry Clin Neurosci, 71, pp.6~17 (2017)
- Torales J, "The outbreak of COVID-19 coronavirus and its impact on global mental health", Int J Soc Psychiatry, 66, pp.317~320 (2020)
- Archard D, "Is it wrong to prioritise younger patients with COVID-19?", BMJ, 369, pp.m1509~ (2020)
- Yin X, "An acute manic episode during 2019-nCoV quarantine", J Affect Disord, 276, pp.623~625 (2020)
- Teresa Arora, "The prevalence of psychological consequences of COVID-19: A systematic review and meta-analysis of observational studies", Journal of Health Psychology, 27(4), pp.805~824 (2022), SAGE Publications[DOI]